Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Real-world, Multi-center, Prospective, Observational Study for PNH in China

NCT06154512

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Research Site Hefei, Anhui, China

Research Site Beijing, Beijing Municipality, China

Research Site Beijing, Beijing Municipality, China

Research Site Guangzhou, Guangdong, China

View all 40 locations

View Trial Details

Completed

To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.

NCT07291986

Conditions: Cytopenia, Eye Diseases, Hematologic Diseases, +18 more
Locations: Faculty of Medicine, Fayoum University Al Fayyum, Egypt

View Trial Details

Completed

Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

NCT06355323

Conditions: Blood Protein Disorders, Common Variable Immunodeficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Damien JOLLY Reims, France

View Trial Details

Completed

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

NCT03573310

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Florida Specialist and Cancer Institute Sarasota, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Ohio State University Columbus, Ohio, United States

University of Texas, MD Anderson Cancer Center Houston, Texas, United States

View all 18 locations

View Trial Details

Completed

Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

NCT02461888

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Queen Elizabeth Medical Centre Birmingham, United Kingdom

Heart of England NHS Foundation Trust Birmingham, United Kingdom

Royal Bournemouth General Hospital Bournemouth, United Kingdom

University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom

View all 18 locations

View Trial Details

Completed

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

NCT03317899

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Stem Cell Gene Therapy for Sickle Cell Disease

NCT02247843

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: University of California, Los Angeles (UCLA) Los Angeles, California, United States

View Trial Details

Completed

Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment

NCT02881086

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: University Hospital of Frankfurt (Main) Frankfurt am Main, Germany

View Trial Details

Completed

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

NCT06030089

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hopital la Conception Marseille, France

CHU de Nice Nice, France

View Trial Details

Completed

Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State

NCT06768619

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations: Changchun University of Traditional Chinese Medicine Affiliated Hospital Changchun, Jilin, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions